Reader Comment Regarding “Survey of Oncologists and Dermatologists in Canada on the Management of Acneiform Eruptions Induced by Epidermal Growth Factor Receptor Inhibitors”

Abstract

Keywords

acne acneiform eruption targeted therapy EGFR inhibitors epidermal growth factor receptor inhibitor retinoid

Get full access to this article

View all access options for this article.

References

Sanmartín

. Skin manifestations of targeted antineoplastic therapy. Curr Probl Dermatol. 2018;53:93-104.doi:10.1159/000479198

29131041

Lacouture

ME.

Mitchell

EP.

Piperdi

et al. Skin toxicity evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-emptive skin treatment regimen on skin toxicities and quality of life in patients with metastatic colorectal cancer. J Clin Oncol. 2010;28(8):1351-1357.doi:10.1200/JCO.2008.21.7828

20142600

Burtness

Anadkat

Basti

et al. NCCN Task force report: management of dermatologic and other toxicities associated with EGFR inhibition in patients with cancer. J Natl Compr Canc Netw. 2009;7(Suppl 1):S5-S21.doi:10.6004/jnccn.2009.0074

19470276

Scope

Agero

ALC.

Dusza

et al. Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption. J Clin Oncol. 2007;25(34):5390-5396.doi:10.1200/JCO.2007.12.6987

18048820